Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Multiplicity of Asymptomatic Plasmodium falciparum Infections and Risk of Clinical Malaria: A Systematic Review and Pooled Analysis of Individual Participant Data.

Eldh M, Hammar U, Arnot D, Beck HP, Garcia A, Liljander A, Mercereau-Puijalon O, Migot-Nabias F, Mueller I, Ntoumi F, Ross A, Smith T, Sondén K, Vafa Homann M, Yman V, Felger I, Färnert A.

J Infect Dis. 2020 Feb 18;221(5):775-785. doi: 10.1093/infdis/jiz510.

2.

Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection.

Howard J, Zaidi I, Loizon S, Mercereau-Puijalon O, Déchanet-Merville J, Mamani-Matsuda M.

Front Immunol. 2018 Nov 27;9:2760. doi: 10.3389/fimmu.2018.02760. eCollection 2018. Review.

3.

Sensing of red blood cells with decreased membrane deformability by the human spleen.

Safeukui I, Buffet PA, Deplaine G, Perrot S, Brousse V, Sauvanet A, Aussilhou B, Dokmak S, Couvelard A, Cazals-Hatem D, Mercereau-Puijalon O, Milon G, David PH, Mohandas N.

Blood Adv. 2018 Oct 23;2(20):2581-2587. doi: 10.1182/bloodadvances.2018024562.

4.

Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.

Perraut R, Varela ML, Joos C, Diouf B, Sokhna C, Mbengue B, Tall A, Loucoubar C, Touré A, Mercereau-Puijalon O.

Vaccine. 2017 Dec 4;35(48 Pt B):6720-6726. doi: 10.1016/j.vaccine.2017.10.012. Epub 2017 Oct 15.

PMID:
29042203
5.

Serological signatures of declining exposure following intensification of integrated malaria control in two rural Senegalese communities.

Perraut R, Varela ML, Loucoubar C, Niass O, Sidibé A, Tall A, Trape JF, Wotodjo AN, Mbengue B, Sokhna C, Vigan-Womas I, Touré A, Richard V, Mercereau-Puijalon O.

PLoS One. 2017 Jun 13;12(6):e0179146. doi: 10.1371/journal.pone.0179146. eCollection 2017.

6.

The Antigen-Presenting Potential of Vγ9Vδ2 T Cells During Plasmodium falciparum Blood-Stage Infection.

Howard J, Loizon S, Tyler CJ, Duluc D, Moser B, Mechain M, Duvignaud A, Malvy D, Troye-Blomberg M, Moreau JF, Eberl M, Mercereau-Puijalon O, Déchanet-Merville J, Behr C, Mamani-Matsuda M.

J Infect Dis. 2017 May 15;215(10):1569-1579. doi: 10.1093/infdis/jix149.

PMID:
28368498
7.

A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.

Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, Chy S, Kim S, Ke S, Kloeung N, Eam R, Khean C, Ken M, Loch K, Bouillon A, Domergue A, Ma L, Bouchier C, Leang R, Huy R, Nuel G, Barale JC, Legrand E, Ringwald P, Fidock DA, Mercereau-Puijalon O, Ariey F, Ménard D.

Lancet Infect Dis. 2017 Feb;17(2):174-183. doi: 10.1016/S1473-3099(16)30415-7. Epub 2016 Nov 3. Erratum in: Lancet Infect Dis. 2018 Aug;18(8):829.

8.

A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.

Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, Rahim-Awab G, Barnadas C, Berry A, Boum Y, Bustos MD, Cao J, Chen JH, Collet L, Cui L, Thakur GD, Dieye A, Djallé D, Dorkenoo MA, Eboumbou-Moukoko CE, Espino FE, Fandeur T, Ferreira-da-Cruz MF, Fola AA, Fuehrer HP, Hassan AM, Herrera S, Hongvanthong B, Houzé S, Ibrahim ML, Jahirul-Karim M, Jiang L, Kano S, Ali-Khan W, Khanthavong M, Kremsner PG, Lacerda M, Leang R, Leelawong M, Li M, Lin K, Mazarati JB, Ménard S, Morlais I, Muhindo-Mavoko H, Musset L, Na-Bangchang K, Nambozi M, Niaré K, Noedl H, Ouédraogo JB, Pillai DR, Pradines B, Quang-Phuc B, Ramharter M, Randrianarivelojosia M, Sattabongkot J, Sheikh-Omar A, Silué KD, Sirima SB, Sutherland C, Syafruddin D, Tahar R, Tang LH, Touré OA, Tshibangu-wa-Tshibangu P, Vigan-Womas I, Warsame M, Wini L, Zakeri S, Kim S, Eam R, Berne L, Khean C, Chy S, Ken M, Loch K, Canier L, Duru V, Legrand E, Barale JC, Stokes B, Straimer J, Witkowski B, Fidock DA, Rogier C, Ringwald P, Ariey F, Mercereau-Puijalon O; KARMA Consortium.

N Engl J Med. 2016 Jun 23;374(25):2453-64. doi: 10.1056/NEJMoa1513137.

9.

Plasmodium falciparum parasite population structure and gene flow associated to anti-malarial drugs resistance in Cambodia.

Dwivedi A, Khim N, Reynes C, Ravel P, Ma L, Tichit M, Bourchier C, Kim S, Dourng D, Khean C, Chim P, Siv S, Frutos R, Lek D, Mercereau-Puijalon O, Ariey F, Menard D, Cornillot E.

Malar J. 2016 Jun 14;15:319. doi: 10.1186/s12936-016-1370-y.

10.

Plasmodium falciparum: multifaceted resistance to artemisinins.

Paloque L, Ramadani AP, Mercereau-Puijalon O, Augereau JM, Benoit-Vical F.

Malar J. 2016 Mar 9;15:149. doi: 10.1186/s12936-016-1206-9. Review.

11.

Functional analysis of monoclonal antibodies against the Plasmodium falciparum PfEMP1-VarO adhesin.

Guillotte M, Nato F, Juillerat A, Hessel A, Marchand F, Lewit-Bentley A, Bentley GA, Vigan-Womas I, Mercereau-Puijalon O.

Malar J. 2016 Jan 15;15:28. doi: 10.1186/s12936-015-1016-5.

12.

Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations.

Duru V, Khim N, Leang R, Kim S, Domergue A, Kloeung N, Ke S, Chy S, Eam R, Khean C, Loch K, Ken M, Lek D, Beghain J, Ariey F, Guerin PJ, Huy R, Mercereau-Puijalon O, Witkowski B, Menard D.

BMC Med. 2015 Dec 22;13:305. doi: 10.1186/s12916-015-0539-5.

13.

Antibodies to Plasmodium falciparum merozoite surface protein-1p19 malaria vaccine candidate induce antibody-dependent respiratory burst in human neutrophils.

Joos C, Varela ML, Mbengue B, Mansourou A, Marrama L, Sokhna C, Tall A, Trape JF, Touré A, Mercereau-Puijalon O, Perraut R.

Malar J. 2015 Oct 15;14:409. doi: 10.1186/s12936-015-0935-5.

14.

Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure.

Ménard S, Ben Haddou T, Ramadani AP, Ariey F, Iriart X, Beghain J, Bouchier C, Witkowski B, Berry A, Mercereau-Puijalon O, Benoit-Vical F.

Emerg Infect Dis. 2015 Oct;21(10):1733-41. doi: 10.3201/eid2110.150682.

15.

Genetic determinants of anti-malarial acquired immunity in a large multi-centre study.

Shelton JM, Corran P, Risley P, Silva N, Hubbart C, Jeffreys A, Rowlands K, Craik R, Cornelius V, Hensmann M, Molloy S, Sepulveda N, Clark TG, Band G, Clarke GM, Spencer CC, Kerasidou A, Campino S, Auburn S, Tall A, Ly AB, Mercereau-Puijalon O, Sakuntabhai A, Djimdé A, Maiga B, Touré O, Doumbo OK, Dolo A, Troye-Blomberg M, Mangano VD, Verra F, Modiano D, Bougouma E, Sirima SB, Ibrahim M, Hussain A, Eid N, Elzein A, Mohammed H, Elhassan A, Elhassan I, Williams TN, Ndila C, Macharia A, Marsh K, Manjurano A, Reyburn H, Lemnge M, Ishengoma D, Carter R, Karunaweera N, Fernando D, Dewasurendra R, Drakeley CJ, Riley EM, Kwiatkowski DP, Rockett KA; MalariaGEN Consortium.

Malar J. 2015 Aug 28;14:333. doi: 10.1186/s12936-015-0833-x.

16.

Risk factors associated with asthma, atopic dermatitis and rhinoconjunctivitis in a rural Senegalese cohort.

Herrant M, Loucoubar C, Boufkhed S, Bassène H, Sarr FD, Baril L, Mercereau-Puijalon O, Mécheri S, Sakuntabhai A, Paul R.

Allergy Asthma Clin Immunol. 2015 Aug 25;11(1):24. doi: 10.1186/s13223-015-0090-0. eCollection 2015.

17.

Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes.

Guillotte M, Juillerat A, Igonet S, Hessel A, Petres S, Crublet E, Le Scanf C, Lewit-Bentley A, Bentley GA, Vigan-Womas I, Mercereau-Puijalon O.

PLoS One. 2015 Jul 29;10(7):e0134292. doi: 10.1371/journal.pone.0134292. eCollection 2015.

18.

Phosphoantigen Burst upon Plasmodium falciparum Schizont Rupture Can Distantly Activate Vγ9Vδ2 T Cells.

Guenot M, Loizon S, Howard J, Costa G, Baker DA, Mohabeer SY, Troye-Blomberg M, Moreau JF, Déchanet-Merville J, Mercereau-Puijalon O, Mamani-Matsuda M, Behr C.

Infect Immun. 2015 Oct;83(10):3816-24. doi: 10.1128/IAI.00446-15. Epub 2015 Jul 13.

19.

cAMP-Signalling Regulates Gametocyte-Infected Erythrocyte Deformability Required for Malaria Parasite Transmission.

Ramdani G, Naissant B, Thompson E, Breil F, Lorthiois A, Dupuy F, Cummings R, Duffier Y, Corbett Y, Mercereau-Puijalon O, Vernick K, Taramelli D, Baker DA, Langsley G, Lavazec C.

PLoS Pathog. 2015 May 7;11(5):e1004815. doi: 10.1371/journal.ppat.1004815. eCollection 2015 May.

20.

Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.

Straimer J, Gnädig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, Dacheux M, Khim N, Zhang L, Lam S, Gregory PD, Urnov FD, Mercereau-Puijalon O, Benoit-Vical F, Fairhurst RM, Ménard D, Fidock DA.

Science. 2015 Jan 23;347(6220):428-31. doi: 10.1126/science.1260867. Epub 2014 Dec 11.

21.

Red cells from ferrochelatase-deficient erythropoietic protoporphyria patients are resistant to growth of malarial parasites.

Smith CM, Jerkovic A, Puy H, Winship I, Deybach JC, Gouya L, van Dooren G, Goodman CD, Sturm A, Manceau H, McFadden GI, David P, Mercereau-Puijalon O, Burgio G, McMorran BJ, Foote SJ.

Blood. 2015 Jan 15;125(3):534-41. doi: 10.1182/blood-2014-04-567149. Epub 2014 Nov 20.

22.

Comparative analysis of IgG responses to Plasmodium falciparum MSP1p19 and PF13-DBL1α1 using ELISA and a magnetic bead-based duplex assay (MAGPIX®-Luminex) in a Senegalese meso-endemic community.

Perraut R, Richard V, Varela ML, Trape JF, Guillotte M, Tall A, Toure A, Sokhna C, Vigan-Womas I, Mercereau-Puijalon O.

Malar J. 2014 Oct 17;13:410. doi: 10.1186/1475-2875-13-410.

23.

Effects of mefloquine use on Plasmodium vivax multidrug resistance.

Khim N, Andrianaranjaka V, Popovici J, Kim S, Ratsimbasoa A, Benedet C, Barnadas C, Durand R, Thellier M, Legrand E, Musset L, Menegon M, Severini C, Nour BY, Tichit M, Bouchier C, Mercereau-Puijalon O, Ménard D.

Emerg Infect Dis. 2014 Oct;20(10):1637-44. doi: 10.3201/eid2010.140411.

24.

A novel Plasmodium-specific prodomain fold regulates the malaria drug target SUB1 subtilase.

Giganti D, Bouillon A, Tawk L, Robert F, Martinez M, Crublet E, Weber P, Girard-Blanc C, Petres S, Haouz A, Hernandez JF, Mercereau-Puijalon O, Alzari PM, Barale JC.

Nat Commun. 2014 Sep 10;5:4833. doi: 10.1038/ncomms5833.

PMID:
25204226
25.

Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia.

Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, Fukuda MM, Hien TT, Mayxay M, Noedl H, Nosten F, Kyaw MP, Nhien NT, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Ariey F, Mercereau-Puijalon O, Menard D, Newton PN, Khanthavong M, Hongvanthong B, Starzengruber P, Fuehrer HP, Swoboda P, Khan WA, Phyo AP, Nyunt MM, Nyunt MH, Brown TS, Adams M, Pepin CS, Bailey J, Tan JC, Ferdig MT, Clark TG, Miotto O, MacInnis B, Kwiatkowski DP, White NJ, Ringwald P, Plowe CV.

J Infect Dis. 2015 Mar 1;211(5):670-9. doi: 10.1093/infdis/jiu491. Epub 2014 Sep 1.

26.

[Towards a better understanding of the molecular mechanisms of P. falciparum resistance to artemisinin].

Khim N, Witkowski B, Duru V, Ariey F, Mercereau-Puijalon O, Ménard D.

Med Sci (Paris). 2014 Aug-Sep;30(8-9):727-9. doi: 10.1051/medsci/20143008004. Epub 2014 Sep 1. French. No abstract available.

27.

Molecular surveillance for artemisinin resistance in Africa.

Roper C, Alifrangis M, Ariey F, Talisuna A, Menard D, Mercereau-Puijalon O, Ringwald P.

Lancet Infect Dis. 2014 Aug;14(8):668-670. doi: 10.1016/S1473-3099(14)70826-6. No abstract available.

PMID:
25056012
28.

Association of antibody responses to the conserved Plasmodium falciparum merozoite surface protein 5 with protection against clinical malaria.

Perraut R, Joos C, Sokhna C, Polson HE, Trape JF, Tall A, Marrama L, Mercereau-Puijalon O, Richard V, Longacre S.

PLoS One. 2014 Jul 21;9(7):e101737. doi: 10.1371/journal.pone.0101737. eCollection 2014.

29.

The rise and fall of malaria in a West African rural community, Dielmo, Senegal, from 1990 to 2012: a 22 year longitudinal study.

Trape JF, Tall A, Sokhna C, Ly AB, Diagne N, Ndiath O, Mazenot C, Richard V, Badiane A, Dieye-Ba F, Faye J, Ndiaye G, Diene Sarr F, Roucher C, Bouganali C, Bassène H, Touré-Baldé A, Roussilhon C, Perraut R, Spiegel A, Sarthou JL, da Silva LP, Mercereau-Puijalon O, Druilhe P, Rogier C.

Lancet Infect Dis. 2014 Jun;14(6):476-88. doi: 10.1016/S1473-3099(14)70712-1. Epub 2014 May 6.

PMID:
24813159
30.

Global analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinine.

Ménard D, Andriantsoanirina V, Khim N, Ratsimbasoa A, Witkowski B, Benedet C, Canier L, Mercereau-Puijalon O, Durand R.

Int J Parasitol Drugs Drug Resist. 2012 Oct 26;3:8-19. doi: 10.1016/j.ijpddr.2012.10.001. eCollection 2013 Dec. Review.

31.

An exported kinase (FIKK4.2) that mediates virulence-associated changes in Plasmodium falciparum-infected red blood cells.

Kats LM, Fernandez KM, Glenister FK, Herrmann S, Buckingham DW, Siddiqui G, Sharma L, Bamert R, Lucet I, Guillotte M, Mercereau-Puijalon O, Cooke BM.

Int J Parasitol. 2014 Apr;44(5):319-28. doi: 10.1016/j.ijpara.2014.01.003. Epub 2014 Feb 14.

PMID:
24530877
32.

Reduced erythrocyte deformability associated with hypoargininemia during Plasmodium falciparum malaria.

Rey J, Buffet PA, Ciceron L, Milon G, Mercereau-Puijalon O, Safeukui I.

Sci Rep. 2014 Jan 20;4:3767. doi: 10.1038/srep03767.

33.

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D.

Nature. 2014 Jan 2;505(7481):50-5. doi: 10.1038/nature12876. Epub 2013 Dec 18.

34.

De novo assembly of a field isolate genome reveals novel Plasmodium vivax erythrocyte invasion genes.

Hester J, Chan ER, Menard D, Mercereau-Puijalon O, Barnwell J, Zimmerman PA, Serre D.

PLoS Negl Trop Dis. 2013 Dec 5;7(12):e2569. doi: 10.1371/journal.pntd.0002569. eCollection 2013.

35.

Whole genome sequencing of field isolates reveals a common duplication of the Duffy binding protein gene in Malagasy Plasmodium vivax strains.

Menard D, Chan ER, Benedet C, Ratsimbasoa A, Kim S, Chim P, Do C, Witkowski B, Durand R, Thellier M, Severini C, Legrand E, Musset L, Nour BY, Mercereau-Puijalon O, Serre D, Zimmerman PA.

PLoS Negl Trop Dis. 2013 Nov 21;7(11):e2489. doi: 10.1371/journal.pntd.0002489. eCollection 2013 Nov.

36.

A key role for Plasmodium subtilisin-like SUB1 protease in egress of malaria parasites from host hepatocytes.

Tawk L, Lacroix C, Gueirard P, Kent R, Gorgette O, Thiberge S, Mercereau-Puijalon O, Ménard R, Barale JC.

J Biol Chem. 2013 Nov 15;288(46):33336-46. doi: 10.1074/jbc.M113.513234. Epub 2013 Oct 2.

37.

Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies.

Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, Lim P, Mao S, Sopha C, Sam B, Anderson JM, Duong S, Chuor CM, Taylor WR, Suon S, Mercereau-Puijalon O, Fairhurst RM, Menard D.

Lancet Infect Dis. 2013 Dec;13(12):1043-9. doi: 10.1016/S1473-3099(13)70252-4. Epub 2013 Sep 11.

38.

Asthma and atopic dermatitis are associated with increased risk of clinical Plasmodium falciparum malaria.

Herrant M, Loucoubar C, Bassène H, Gonçalves B, Boufkhed S, Diene Sarr F, Fontanet A, Tall A, Baril L, Mercereau-Puijalon O, Mécheri S, Sakuntabhai A, Paul R.

BMJ Open. 2013 Jul 24;3(7). pii: e002835. doi: 10.1136/bmjopen-2013-002835. Print 2013.

39.

[Plasmodium falciparum susceptibility to antimalarial drugs: global data issued from the Pasteur Institutes international network].

Ménard D, Ariey F, Mercereau-Puijalon O.

Med Sci (Paris). 2013 Jun-Jul;29(6-7):647-55. doi: 10.1051/medsci/2013296020. Epub 2013 Jul 12. Review. French.

40.

In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound.

Bouillon A, Giganti D, Benedet C, Gorgette O, Pêtres S, Crublet E, Girard-Blanc C, Witkowski B, Ménard D, Nilges M, Mercereau-Puijalon O, Stoven V, Barale JC.

J Biol Chem. 2013 Jun 21;288(25):18561-73. doi: 10.1074/jbc.M113.456764. Epub 2013 May 7.

41.

Surface area loss and increased sphericity account for the splenic entrapment of subpopulations of Plasmodium falciparum ring-infected erythrocytes.

Safeukui I, Buffet PA, Perrot S, Sauvanet A, Aussilhou B, Dokmak S, Couvelard A, Hatem DC, Mohandas N, David PH, Mercereau-Puijalon O, Milon G.

PLoS One. 2013;8(3):e60150. doi: 10.1371/journal.pone.0060150. Epub 2013 Mar 28.

42.

High number of previous Plasmodium falciparum clinical episodes increases risk of future episodes in a sub-group of individuals.

Loucoubar C, Grange L, Paul R, Huret A, Tall A, Telle O, Roussilhon C, Faye J, Diene-Sarr F, Trape JF, Mercereau-Puijalon O, Sakuntabhai A, Bureau JF.

PLoS One. 2013;8(2):e55666. doi: 10.1371/journal.pone.0055666. Epub 2013 Feb 6.

43.

Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Zimmerman PA, Ferreira MU, Howes RE, Mercereau-Puijalon O.

Adv Parasitol. 2013;81:27-76. doi: 10.1016/B978-0-12-407826-0.00002-3. Review.

44.

Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia.

Witkowski B, Khim N, Chim P, Kim S, Ke S, Kloeung N, Chy S, Duong S, Leang R, Ringwald P, Dondorp AM, Tripura R, Benoit-Vical F, Berry A, Gorgette O, Ariey F, Barale JC, Mercereau-Puijalon O, Menard D.

Antimicrob Agents Chemother. 2013 Feb;57(2):914-23. doi: 10.1128/AAC.01868-12. Epub 2012 Dec 3.

45.

Screening and evaluation of inhibitors of Plasmodium falciparum merozoite egress and invasion using cytometry.

Bouillon A, Gorgette O, Mercereau-Puijalon O, Barale JC.

Methods Mol Biol. 2013;923:523-34.

PMID:
22990802
46.

Microsphiltration: a microsphere matrix to explore erythrocyte deformability.

Lavazec C, Deplaine G, Safeukui I, Perrot S, Milon G, Mercereau-Puijalon O, David PH, Buffet P.

Methods Mol Biol. 2013;923:291-7.

PMID:
22990786
47.

Whole genome sequencing of field isolates provides robust characterization of genetic diversity in Plasmodium vivax.

Chan ER, Menard D, David PH, Ratsimbasoa A, Kim S, Chim P, Do C, Witkowski B, Mercereau-Puijalon O, Zimmerman PA, Serre D.

PLoS Negl Trop Dis. 2012;6(9):e1811. doi: 10.1371/journal.pntd.0001811. Epub 2012 Sep 6.

48.

Pf155/RESA protein influences the dynamic microcirculatory behavior of ring-stage Plasmodium falciparum infected red blood cells.

Diez-Silva M, Park Y, Huang S, Bow H, Mercereau-Puijalon O, Deplaine G, Lavazec C, Perrot S, Bonnefoy S, Feld MS, Han J, Dao M, Suresh S.

Sci Rep. 2012;2:614. doi: 10.1038/srep00614. Epub 2012 Aug 30.

49.

Structural basis for the ABO blood-group dependence of Plasmodium falciparum rosetting.

Vigan-Womas I, Guillotte M, Juillerat A, Hessel A, Raynal B, England P, Cohen JH, Bertrand O, Peyrard T, Bentley GA, Lewit-Bentley A, Mercereau-Puijalon O.

PLoS Pathog. 2012;8(7):e1002781. doi: 10.1371/journal.ppat.1002781. Epub 2012 Jul 12.

50.

Possible association of the Plasmodium falciparum T1526C resa2 gene mutation with severe malaria.

Durand R, Migot-Nabias F, Andriantsoanirina V, Seringe E, Viwami F, Sagbo G, Lalya F, Deloron P, Mercereau-Puijalon O, Bonnefoy S.

Malar J. 2012 Apr 25;11:128. doi: 10.1186/1475-2875-11-128.

Supplemental Content

Loading ...
Support Center